Posted by Michael Wonder on 23 Mar 2020
Coronavirus patients in limbo as Gilead suspends emergency drug access
23 March 2020 - The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
Overwhelmed by demand for an experimental treatment for coronavirus, the drug maker Gilead abruptly shut down its emergency access program, leaving doctors and families scrambling for answers.
The company said it was setting up a broader access program that could try to help more people, but some said the transition is delaying remedies for very ill patients who have few options.
